[account_shop_links]
Attributes Gaining Importance When Selecting Among Preferred Providers for Phase I Services
Attributes Gaining Importance When Selecting Among Preferred Providers for Phase I Services
Decentralized Clinical Trial Predicted Use
Decentralized Clinical Trial Predicted Use
How Well Are CDMOs Performing on Sponsors’ Most Important CDMO Selection Criteria
How Well Are CDMOs Performing on Sponsors’ Most Important CDMO Selection Criteria
Clinical Manufacturing Volume by Service Provider Category
Clinical Manufacturing Volume by Service Provider Category
Phase I Study Complexity
Phase I Study Complexity
The Top Reasons Bioprocessing CDMOs Lose Bids
The Top Reasons Bioprocessing CDMOs Lose Bids
Preferred Provider Agreements at Small & Emerging Sponsors
Preferred Provider Agreements at Small & Emerging Sponsors
Outsourced Proportion of Phase II/III Spend
Outsourced Proportion of Phase II/III Spend
Volume of Trials with Outsourced Clinical Logistics
Volume of Trials with Outsourced Clinical Logistics
Predicted Changes in Outsourcing Rates for Highly Potent API
Predicted Changes in Outsourcing Rates for Highly Potent API
Phase II/III Service Provider Attributes Gaining in Selection Importance
Phase II/III Service Provider Attributes Gaining in Selection Importance
Preferred Provider Agreements for Phase I Services
